Author:
Hunt Allison L.,Bateman Nicholas W.,Barakat Waleed,Makohon-Moore Sasha,Hood Brian L.,Conrads Kelly A.,Zhou Ming,Calvert Valerie,Pierobon Mariaelena,Loffredo Jeremy,Litzi Tracy J.,Oliver Julie,Mitchell Dave,Gist Glenn,Rojas Christine,Blanton Brian,Robinson Emma L.,Odunsi Kunle,Sood Anil K.,Casablanca Yovanni,Darcy Kathleen M.,Shriver Craig D.,Petricoin Emanuel F.,Rao Uma N. M.,Maxwell G. Larry,Conrads Thomas P.
Abstract
AbstractEnriched tumor epithelium, tumor-associated stroma, and whole tissue were collected by laser microdissection from thin sections across spatially separated levels of ten primary high-grade serous ovarian tumors and analyzed using proteomics (mass spectrometry and reverse phase protein microarray) and RNA-sequencing analyses. Comparative analyses of transcript and protein abundances revealed independent clustering of enriched stroma and enriched tumor epithelium, with whole tumor tissue clustering between purified collections, driven by overall tumor purity. Comparison of historic prognostic molecular subtypes for HGSOC revealed protein and transcript expression from tumor epithelium correlated most strongly with the differentiated molecular subtype, whereas stromal proteins and transcripts most strongly correlated with mesenchymal subtype. Protein and transcript abundance in tumor epithelium and stromal collections from neighboring sections exhibited decreased correlation in samples collected just hundreds of microns apart. These data reveal substantial protein and transcript expression heterogeneity within the tumor microenvironment that directly bears on prognostic signatures and underscore the need to enrich cellular subpopulations for expression profiling.
Publisher
Cold Spring Harbor Laboratory
Reference63 articles.
1. Siegel, R.L. , K.D. Miller , and A. Jemal , Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 2020. 70(1): p. 7–30.
2. Noone AM, H.N. , Krapcho M , Miller D , Brest A , Yu M , Ruhl J , Tatalovich Z , Mariotto A , Lewis DR , Chen HS , Feuer EJ , Cronin KA (eds), SEER Cancer Statistics Review, 1975 -2015. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, April 2018. based on November 2017 SEER data submission, posted to the SEER web site.
3. Integrated genomic analyses of ovarian carcinoma
4. Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
5. Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient